Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model
出版年份 2018 全文链接
标题
Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model
作者
关键词
Pancreatic adenocarcinoma, Cotranslational translocation, Secretory pathway, Drug resistance
出版物
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-03
DOI
10.1007/s10637-018-0647-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease
- (2017) Kristina L. Go et al. PANCREAS
- Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors
- (2017) Weijing Cai et al. ACS Medicinal Chemistry Letters
- Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture
- (2016) Kien Pham et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
- (2016) Kuan-Chun Huang et al. MOLECULAR CANCER THERAPEUTICS
- Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements
- (2015) Daniel Delitto et al. AMERICAN JOURNAL OF PATHOLOGY
- Recent advances in pancreatic cancer: biology, treatment, and prevention
- (2015) Divya Singh et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Primary outgrowth cultures are a reliable source of human pancreatic stellate cells
- (2015) Song Han et al. LABORATORY INVESTIGATION
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity
- (2014) Qi-Yin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apratoxin H and Apratoxin A Sulfoxide from the Red Sea Cyanobacterium Moorea producens
- (2013) Christopher C. Thornburg et al. JOURNAL OF NATURAL PRODUCTS
- Targeting Tumor Architecture to Favor Drug Penetration: A New Weapon to Combat Chemoresistance in Pancreatic Cancer?
- (2012) Man Yu et al. CANCER CELL
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Regional Intra-Arterial vs. Systemic Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2012) Fenghua Liu et al. PLoS One
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
- (2011) Feng Yang et al. CANCER TREATMENT REVIEWS
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Five Primary Human Pancreatic Adenocarcinoma Cell Lines Established by the Outgrowth Method
- (2011) Felix Rückert et al. JOURNAL OF SURGICAL RESEARCH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity
- (2011) Qi-Yin Chen et al. ACS Medicinal Chemistry Letters
- Evolved Diversification of a Modular Natural Product Pathway: Apratoxins F and G, Two Cytotoxic Cyclic Depsipeptides from a Palmyra Collection of Lyngbya bouillonii
- (2010) Kevin Tidgewell et al. CHEMBIOCHEM
- Neural and hormonal regulation of pancreatic secretion
- (2009) Rashmi Chandra et al. CURRENT OPINION IN GASTROENTEROLOGY
- Apratoxin A Reversibly Inhibits the Secretory Pathway by Preventing Cotranslational Translocation
- (2009) Y. Liu et al. MOLECULAR PHARMACOLOGY
- Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
- (2009) Subhash Padhye et al. PHARMACEUTICAL RESEARCH
- Apratoxin E, a Cytotoxic Peptolide from a Guamanian Collection of the Marine CyanobacteriumLyngbya bouillonii
- (2008) Susan Matthew et al. JOURNAL OF NATURAL PRODUCTS
- Apratoxin D, a Potent Cytotoxic Cyclodepsipeptide from Papua New Guinea Collections of the Marine CyanobacteriaLyngbya majusculaandLyngbya sordida
- (2008) Marcelino Gutiérrez et al. JOURNAL OF NATURAL PRODUCTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started